Mizuho Issues Pessimistic Forecast for Verastem (NASDAQ:VSTM) Stock Price

Verastem (NASDAQ:VSTM – Get Free Report) had its price objective cut by Mizuho from $9.00 to $8.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target indicates a potential upside of 76.99% from the company’s current price. Other equities research analysts also […]